July 25, 2016
Teens who participate in daily sports and exercise activities are less likely to transition from opioid pain reliever use to heroin, according to research funded by the National Institute on Drug Abuse (NIDA), and published today in Pediatrics.
There have been anecdotal reports of teen athletes being prescribed opioid pain relievers for injuries, who later transition to nonmedical use of opioid pain pills and then turn to heroin. However, this study found that sports activities may have a protective effect related to that potential transition.
Researchers from the University of Michigan at Ann Arbor looked at 18 cross sections of eighth and tenth grade responses in NIDA’s Monitoring the Future (MTF) survey, answered between 1997 and 2014. While the survey measures prevalence of drug use, it also collects secondary data, including information related to involvement in athletics. NIDA’s MTF survey is conducted annually by a separate team of scientists at the University of Michigan.
For a copy of the abstract, "Nonmedical Prescription Opioid and Heroin Use Among Adolescents Who Engage in Sports and Exercise," published in Pediatrics, go to http://pediatrics.aappublications.org/content/early/2016/07/21/peds.2016-0677.
To learn more about prescription opioids and heroin go to: https://www.drugabuse.gov/publications/research-reports/relationship-between-prescription-drug-abuse-heroin-use/introduction
For more information, contact the NIDA press office at media@nida.nih.gov or 301-443-6245. Follow NIDA on Twitter and Facebook.
Contact:
NIDA Press Office
301-443-6245
media@nida.nih.gov
About the National Institute on Drug Abuse (NIDA): The National Institute on Drug Abuse (NIDA) is a component of the National Institutes of Health, U.S. Department of Health and Human Services. NIDA supports most of the world’s research on the health aspects of drug use and addiction. The Institute carries out a large variety of programs to inform policy, improve practice, and advance addiction science. Fact sheets on the health effects of drugs and information on NIDA research and other activities can be found at www.drugabuse.gov, which is now compatible with your smartphone, iPad or tablet. To order publications in English or Spanish, call NIDA’s DrugPubs research dissemination center at 1-877-NIDA-NIH or 240-645-0228 (TDD) or email requests to drugpubs@nida.nih.gov. Online ordering is available at drugpubs.drugabuse.gov. NIDA’s media guide can be found at www.drugabuse.gov/publications/media-guide/dear-journalist, and its easy-to-read website can be found at www.easyread.drugabuse.gov. You can follow NIDA on Twitter and Facebook.
About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.
NIH. . .Turning Discovery Into Health®
